Evgen's IPO

Evgen raised a round of funding on October 21, 2015. Investors include Public.

Evgen Pharma is a clinical stage drug development company focused on cancer and neurological disease. The company is focused in the development of pharmaceuticals that activate the antioxidant respons…

Articles about Evgen's IPO: